Related Experiment Videos
Low dose aspirin, platelet function and prostaglandin synthesis: influence of epinephrine and alpha adrenergic
Insights
Low-dose aspirin (40-80 mg) selectively inhibits platelet aggregation from arachidonate 16-20 hours post-ingestion. Epinephrine can restore platelet sensitivity to arachidonate by influencing calcium modulation via alpha-adrenergic receptors.
Area of Science:
- Pharmacology
- Hematology
- Biochemistry
Background:
- Aspirin is widely used for its antiplatelet effects.
- Understanding the precise mechanisms and dose-dependency of aspirin's action on platelet function is crucial for optimizing therapeutic strategies.
Purpose of the Study:
- To evaluate the effects of low oral doses of aspirin on platelet prostaglandin synthesis and function.
- To investigate the interaction between aspirin, arachidonate, and epinephrine in modulating platelet aggregation.
Main Methods:
- Administration of low-dose aspirin (40 mg or 80 mg) and standard-dose aspirin (600 mg) to adult subjects.
- Assessment of platelet aggregation in response to thrombin, ADP, epinephrine, and arachidonate at various time points.
- Pharmacological studies using alpha-adrenergic agonists, antagonists, and calcium channel blockers to elucidate the mechanism of epinephrine's effect.
Main Results:
- Low-dose aspirin selectively inhibited platelet aggregation induced by threshold concentrations of arachidonate 16-20 hours after ingestion.
- Higher concentrations of arachidonate could overcome the inhibition by low-dose aspirin but not by standard-dose aspirin.
- Epinephrine, at sub-aggregatory concentrations, restored the sensitivity of aspirin-treated platelets to arachidonate.
Conclusions:
- Low-dose aspirin exhibits selective inhibition of platelet function related to arachidonate pathways.
- Epinephrine's corrective effect on aspirin-impaired platelet function is mediated through alpha-adrenergic receptor modulation of calcium.
- These findings highlight the complex interplay of factors influencing aspirin's antiplatelet efficacy.
Abstract:
The present investigation has evaluated the effects of low doses of oral aspirin on platelet prostaglandin synthesis and function. Whole (80 mg) or half (40 mg) tablets of baby aspirin given to adults had no effect on the response of their platelets to thrombin, ADP and epinephrine, but selectively inhibited aggregation induced by threshold concentrations of arachidonate 16-20 hours after ingestion. Larger amounts of arachidonate overcame the inhibition imposed by low dose aspirin, but not by adult aspirin tablets (600 mg). Epinephrine, in concentrations too low to cause aggregation, restored the sensitivity of aspirin-treated platelets to arachidonate. Studies with alpha-adrenergic agonists, antagonists and calcium channel blockers demonstrated that the corrective effect of epinephrine was mediated by an alpha-adrenergic receptor influence on calcium modulation of the platelet membrane.